peptides in fLorida Med spas: reguLatory Considerations
Health Care law Section
Continued from page 24
hormone-related peptides( sermorelin). These drugs are approved, manufactured under FDA oversight, and widely prescribed for specific medical conditions. However, use of these peptides in med spa settings for indications beyond those approved by the FDA may constitute“ off-label” use.
Other wellness peptides that lack formal FDA approval for human therapeutic use but are marketed for such purposes( often labeled“ for research only” or“ not for human use”) are technically unapproved drugs. Using or promoting them for clinical use can violate the U. S. Food, Drug, and Cosmetic Act( FDCA) and invite enforcement actions including warning letters, product seizures, injunctions, and potential criminal penalties. For med spas, the legality often turns on how the product is sourced, compounded, prescribed, and administered.
Florida law requires that compounded peptides must be obtained from a Florida-licensed compounding pharmacy or an FDA-registered outsourcing facility to ensure patient safety and legal compliance.
Importantly, med spas in Florida must operate under appropriate physician or advanced practice provider oversight. Even with such oversight, clinicians may only prescribe and administer substances that are lawfully compounded or FDA-approved, and marketing must avoid unsubstantiated or disease-treatment claims. Offering peptides as“ wellness” or“ optimization” therapies does not, by itself, remove regulatory scrutiny.
In short, peptides remain an evolving area of enforcement. Florida med spas should view peptides as legally sensitive offerings, requiring careful vetting of suppliers, strict compliance with compounding and prescribing rules, conservative marketing practices, and ongoing legal review. As regulatory priorities continue to develop, staying informed is essential to mitigate risk. n
Author: Mary Baker – Gunster
M A r- A p r 2 0 2 6 | H C B A L A W Y E r
2 5